Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Stanford University |
---|---|
Information provided by: | Stanford University |
ClinicalTrials.gov Identifier: | NCT00186095 |
To evaluate the role of nonmyeloablative allogeneic transplantation in Amyloidosis.
Condition | Intervention |
---|---|
Amyloidosis |
Procedure: autologous followed by nonmyeloablative allogeneic transplant |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment |
Official Title: | Mixed Chimeric Transplantation for Primary Amyloidosis |
Estimated Enrollment: | 45 |
Study Start Date: | December 2000 |
Estimated Study Completion Date: | September 2006 |
Ages Eligible for Study: | up to 60 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | BMT129 |
Study First Received: | September 13, 2005 |
Last Updated: | October 5, 2007 |
ClinicalTrials.gov Identifier: | NCT00186095 History of Changes |
Health Authority: | United States: Institutional Review Board |
Amyloidosis nonmyeloablative hematopoietic cell transplantation |
Amyloidosis Metabolic Diseases Primary Amyloidosis Metabolic Disorder |
Amyloidosis Metabolic Diseases |